AstraZeneca PLC is 22.6x more valuable than Axsome Therapeutics, Inc. by market capitalization ($286.27 B vs $12.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXSM | AZN |
|---|---|---|
| Market cap | $12.68 B | $286.27 B |
| US-listed rank | #813 | #45 |
| Revenue (latest FY) | $638.50M | - |
| Net income (latest FY) | -$183.17M | - |
| Net margin | -28.7% | - |
| SEC filings | 634 | 1,004 |
AstraZeneca PLC is 22.6x more valuable than Axsome Therapeutics, Inc. by market capitalization ($286.27 B vs $12.68 B).
Full pages: Axsome Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.